|
EP0968284B1
(de)
|
1996-11-20 |
2006-12-13 |
Introgen Therapeutics, Inc. |
Ein verbessertes verfahren zur produktion und reinigung von adenoviralen vektoren
|
|
US7732129B1
(en)
*
|
1998-12-01 |
2010-06-08 |
Crucell Holland B.V. |
Method for the production and purification of adenoviral vectors
|
|
US6544769B1
(en)
*
|
1996-12-13 |
2003-04-08 |
Schering Corporation |
Compostions comprising viruses and methods for concentrating virus preparations
|
|
US6689600B1
(en)
|
1998-11-16 |
2004-02-10 |
Introgen Therapeutics, Inc. |
Formulation of adenovirus for gene therapy
|
|
US6225289B1
(en)
*
|
1998-12-10 |
2001-05-01 |
Genvec, Inc. |
Methods and compositions for preserving adenoviral vectors
|
|
US20050164386A1
(en)
*
|
1999-04-15 |
2005-07-28 |
Uytdehaag Alphonsus G. |
Overexpression of enzymes involved in post-translational protein modifications in human cells
|
|
US7297680B2
(en)
*
|
1999-04-15 |
2007-11-20 |
Crucell Holland B.V. |
Compositions of erythropoietin isoforms comprising Lewis-X structures and high sialic acid content
|
|
US7521220B2
(en)
*
|
1999-11-26 |
2009-04-21 |
Crucell Holland B.V. |
Production of vaccines
|
|
US7192759B1
(en)
*
|
1999-11-26 |
2007-03-20 |
Crucell Holland B.V. |
Production of vaccines
|
|
US6168941B1
(en)
|
2000-04-07 |
2001-01-02 |
Genvec, Inc. |
Method of producing adenoviral vector stocks
|
|
US7122376B2
(en)
*
|
2001-11-01 |
2006-10-17 |
Facet Analytical Services And Technology, Llc |
Calibration standards, methods, and kits for water determination
|
|
US7049146B2
(en)
|
2000-11-14 |
2006-05-23 |
Facet Analytical Services And Technology, Llc |
Calibration standards, methods, and kits for water determination
|
|
US20020064860A1
(en)
*
|
2000-11-29 |
2002-05-30 |
Schering Corporation |
Method for purifying adenoviruses
|
|
US6656732B1
(en)
|
2001-05-18 |
2003-12-02 |
Isis Pharmaceuticals, Inc. |
Antisense inhibition of src-c expression
|
|
CA2469491A1
(en)
|
2001-12-12 |
2003-06-19 |
Kerrie Setiawan |
Composition for viral preservation
|
|
US20040106184A1
(en)
*
|
2002-08-28 |
2004-06-03 |
Introgen Therapeutics Inc. |
Chromatographic methods for adenovirus purification
|
|
US7229554B2
(en)
*
|
2002-09-25 |
2007-06-12 |
Novo Nordisk A/S |
Purification process comprising microfiltration at elevated temperatures
|
|
NZ542585A
(en)
*
|
2003-05-09 |
2007-11-30 |
Crucell Holland Bv |
Cultures of PER.C6-immortalized cells and processes for culturing the same to increase product yields therefrom
|
|
US20040229335A1
(en)
*
|
2003-05-15 |
2004-11-18 |
Introgen Therapeutics, Inc. |
Methods and compositions for the production of adenoviral vectors
|
|
CN1922308A
(zh)
*
|
2004-02-23 |
2007-02-28 |
克鲁塞尔荷兰公司 |
病毒纯化方法
|
|
ES2932278T3
(es)
*
|
2004-06-01 |
2023-01-17 |
Genzyme Corp |
Composiciones y métodos para prevenir la agregación del vector AAV
|
|
CN101080488A
(zh)
*
|
2004-11-03 |
2007-11-28 |
因特罗根治疗公司 |
生产和纯化腺病毒载体的新方法
|
|
US20060223053A1
(en)
*
|
2004-11-09 |
2006-10-05 |
Roper D K |
Direct measurement of sorption on three-dimensional surfaces such as resins, membranes or other preformed materials using lateral dispersion to estimate rapid sorption kinetics or high binding capacities
|
|
EP2551282A3
(de)
|
2005-03-23 |
2013-02-13 |
Genmab A/S |
Antikörper gegen CD38 zur Behandling von multiplem Myelom
|
|
ATE412737T1
(de)
*
|
2005-04-11 |
2008-11-15 |
Crucell Holland Bv |
Virusreinigung mit ultrafiltration
|
|
SE528214C2
(sv)
*
|
2005-06-23 |
2006-09-26 |
Proliff Ab |
Förfarande för framställning av blodplättslysat
|
|
US20090093403A1
(en)
|
2007-03-01 |
2009-04-09 |
Feng Zhang |
Systems, methods and compositions for optical stimulation of target cells
|
|
US10052497B2
(en)
*
|
2005-07-22 |
2018-08-21 |
The Board Of Trustees Of The Leland Stanford Junior University |
System for optical stimulation of target cells
|
|
US8926959B2
(en)
|
2005-07-22 |
2015-01-06 |
The Board Of Trustees Of The Leland Stanford Junior University |
System for optical stimulation of target cells
|
|
US9274099B2
(en)
|
2005-07-22 |
2016-03-01 |
The Board Of Trustees Of The Leland Stanford Junior University |
Screening test drugs to identify their effects on cell membrane voltage-gated ion channel
|
|
JP2009502140A
(ja)
*
|
2005-07-22 |
2009-01-29 |
ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー |
光活性化陽イオンチャネルおよびその使用
|
|
US9238150B2
(en)
*
|
2005-07-22 |
2016-01-19 |
The Board Of Trustees Of The Leland Stanford Junior University |
Optical tissue interface method and apparatus for stimulating cells
|
|
CN101528916B
(zh)
|
2006-04-28 |
2013-09-04 |
宾夕法尼亚大学托管会 |
规模可调的aav生产方法
|
|
US8398692B2
(en)
|
2007-01-10 |
2013-03-19 |
The Board Of Trustees Of The Leland Stanford Junior University |
System for optical stimulation of target cells
|
|
US8401609B2
(en)
*
|
2007-02-14 |
2013-03-19 |
The Board Of Trustees Of The Leland Stanford Junior University |
System, method and applications involving identification of biological circuits such as neurological characteristics
|
|
US10434327B2
(en)
*
|
2007-10-31 |
2019-10-08 |
The Board Of Trustees Of The Leland Stanford Junior University |
Implantable optical stimulators
|
|
US10035027B2
(en)
*
|
2007-10-31 |
2018-07-31 |
The Board Of Trustees Of The Leland Stanford Junior University |
Device and method for ultrasonic neuromodulation via stereotactic frame based technique
|
|
CA2703263C
(en)
|
2007-11-01 |
2014-03-18 |
Perseid Therapeutics Llc |
Immunosuppressive polypeptides and nucleic acids
|
|
ES2701349T3
(es)
|
2008-04-23 |
2019-02-21 |
Univ Leland Stanford Junior |
Sistemas, métodos y composiciones para la estimulación óptica de células diana
|
|
EP2294208B1
(de)
|
2008-05-29 |
2013-05-08 |
The Board of Trustees of The Leland Stanford Junior University |
Zelllinie, system und verfahren zur optischen steuerung von sekundären botenstoffen
|
|
JP2011525130A
(ja)
|
2008-06-17 |
2011-09-15 |
ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティ |
光伝送素子を用いた標的細胞の光刺激のための方法、システム、および装置
|
|
EP2303405A4
(de)
*
|
2008-06-17 |
2017-12-27 |
The Board of Trustees of the Leland Stanford Junior University |
Gerät und verfahren zur kontrolle der zellentwicklung
|
|
WO2010006049A1
(en)
|
2008-07-08 |
2010-01-14 |
The Board Of Trustees Of The Leland Stanford Junior University |
Materials and approaches for optical stimulation of the peripheral nervous system
|
|
US20110223635A1
(en)
*
|
2008-08-11 |
2011-09-15 |
Karl Deisseroth |
Method and Composition for Controlling Gene Expression
|
|
EA019928B1
(ru)
|
2008-11-03 |
2014-07-30 |
Круселл Холланд Б.В. |
Способ получения аденовирусных векторов
|
|
NZ602416A
(en)
|
2008-11-14 |
2014-08-29 |
Univ Leland Stanford Junior |
Optically-based stimulation of target cells and modifications thereto
|
|
AU2014240246B2
(en)
*
|
2008-12-05 |
2017-08-10 |
Takeda Vaccines, Inc. |
Compositions, methods and uses for inducing viral growth
|
|
BR122020015754B8
(pt)
*
|
2008-12-05 |
2021-04-06 |
Takeda Vaccines Inc |
métodos para aumentar a taxa de crescimento viral, para aumentar o tamanho da placa de uma cultura viral, para reduzir o tempo de latência do crescimento de uma cultura viral, e para a cultura de vírus para a produção e fabricação
|
|
MX342641B
(es)
|
2010-01-05 |
2016-10-07 |
Vascular Biogenics Ltd |
Metodos para uso de un agente adenoviral anti-angiogenico especifico.
|
|
WO2011097447A2
(en)
*
|
2010-02-04 |
2011-08-11 |
Neurologix, Inc. |
Production of recombinant virus
|
|
US20120315696A1
(en)
*
|
2010-02-15 |
2012-12-13 |
Alfred Luitjens |
METHOD FOR THE PRODUCTION OF Ad26 ADENOVIRAL VECTORS
|
|
EP3399024A1
(de)
|
2010-03-17 |
2018-11-07 |
The Board of Trustees of The Leland Stanford Junior University |
Lichtempfindliche ionendurchgangsmoleküle
|
|
SG184833A1
(en)
|
2010-04-14 |
2012-11-29 |
Emd Millipore Corp |
Methods of producing high titer, high purity virus stocks and methods of use thereof
|
|
CA2808556A1
(en)
|
2010-09-20 |
2012-03-29 |
Crucell Holland B.V. |
Therapeutic vaccination against active tuberculosis
|
|
BR112013004582A2
(pt)
|
2010-09-27 |
2016-09-06 |
Crucell Holland Bv |
método para induzir uma resposta imune em um sujeito contra um antígeno de um parasita que causa a malária
|
|
US9725689B2
(en)
|
2010-10-08 |
2017-08-08 |
Terumo Bct, Inc. |
Configurable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
|
|
US10086012B2
(en)
|
2010-11-05 |
2018-10-02 |
The Board Of Trustees Of The Leland Stanford Junior University |
Control and characterization of memory function
|
|
ES2625179T3
(es)
|
2010-11-05 |
2017-07-18 |
The Board Of Trustees Of The Leland Stanford Junior University |
Control optogenético de comportamientos relacionados con la recompensa
|
|
CN103384469B
(zh)
|
2010-11-05 |
2016-06-15 |
斯坦福大学托管董事会 |
光控cns功能障碍
|
|
EP3486253A1
(de)
|
2010-11-05 |
2019-05-22 |
The Board of Trustees of The Leland Stanford Junior University |
Lichtaktivierte chimäre opsine und verwendungsverfahren dafür
|
|
US10568307B2
(en)
|
2010-11-05 |
2020-02-25 |
The Board Of Trustees Of The Leland Stanford Junior University |
Stabilized step function opsin proteins and methods of using the same
|
|
CN106422081B
(zh)
|
2010-11-05 |
2019-06-21 |
斯坦福大学托管董事会 |
用于光遗传学方法的光的上转换
|
|
US8696722B2
(en)
|
2010-11-22 |
2014-04-15 |
The Board Of Trustees Of The Leland Stanford Junior University |
Optogenetic magnetic resonance imaging
|
|
CA2819236A1
(en)
|
2010-12-02 |
2012-06-07 |
Oncolytics Biotech Inc. |
Lyophilized viral formulations
|
|
MX373096B
(es)
|
2010-12-02 |
2020-04-27 |
Oncolytics Biotech Inc |
Formulaciones virales líquidas.
|
|
WO2013074501A1
(en)
|
2011-11-14 |
2013-05-23 |
Crucell Holland B.V. |
Heterologous prime-boost immunization using measles virus-based vaccines
|
|
CA2859364C
(en)
|
2011-12-16 |
2019-05-07 |
The Board Of Trustees Of The Leland Stanford Junior University |
Opsin polypeptides and methods of use thereof
|
|
ES2628006T3
(es)
|
2012-02-21 |
2017-08-01 |
Circuit Therapeutics, Inc. |
Composiciones para el tratamiento de trastornos neurogénicos del suelo pélvico
|
|
US8932607B2
(en)
|
2012-03-12 |
2015-01-13 |
Crucell Holland B.V. |
Batches of recombinant adenovirus with altered terminal ends
|
|
KR102044051B1
(ko)
|
2012-03-12 |
2019-11-12 |
얀센 백신스 앤드 프리벤션 비.브이. |
터미널 말단이 변경된 재조합 아데노바이러스의 배치
|
|
US9125870B2
(en)
|
2012-03-22 |
2015-09-08 |
Crucell Holland B.V. |
Vaccine against RSV
|
|
JP5845376B2
(ja)
|
2012-03-22 |
2016-01-20 |
クルセル ホランド ベー ヴェー |
Rsvに対するワクチン
|
|
US9636380B2
(en)
|
2013-03-15 |
2017-05-02 |
The Board Of Trustees Of The Leland Stanford Junior University |
Optogenetic control of inputs to the ventral tegmental area
|
|
ES2742492T3
(es)
|
2013-03-15 |
2020-02-14 |
Univ Leland Stanford Junior |
Control optogenético del estado conductual
|
|
PT2988780T
(pt)
|
2013-04-25 |
2019-03-25 |
Janssen Vaccines & Prevention Bv |
Polipeptídeos f de pré-fusão do rsv solúveis estabilizados
|
|
US10220092B2
(en)
|
2013-04-29 |
2019-03-05 |
The Board Of Trustees Of The Leland Stanford Junior University |
Devices, systems and methods for optogenetic modulation of action potentials in target cells
|
|
SG11201510064WA
(en)
|
2013-06-14 |
2016-01-28 |
Psioxus Theraupeutics Ltd |
A dosing regime and formulations for type b adenoviruses
|
|
CN105408348B
(zh)
|
2013-06-17 |
2021-07-06 |
扬森疫苗与预防公司 |
稳定化的可溶性融合前rsv f多肽
|
|
JP6621747B2
(ja)
|
2013-08-14 |
2019-12-18 |
ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー |
疼痛を制御するための組成物及び方法
|
|
KR102272932B1
(ko)
|
2013-10-25 |
2021-07-05 |
싸이오서스 테라퓨틱스 엘티디. |
이종 유전자로 무장된 종양살상 아데노바이러스
|
|
EP3068867B1
(de)
|
2013-11-16 |
2018-04-18 |
Terumo BCT, Inc. |
Zellenexpansion in einem bioreaktor
|
|
US11008547B2
(en)
|
2014-03-25 |
2021-05-18 |
Terumo Bct, Inc. |
Passive replacement of media
|
|
US10577627B2
(en)
|
2014-06-09 |
2020-03-03 |
Voyager Therapeutics, Inc. |
Chimeric capsids
|
|
RU2017110868A
(ru)
|
2014-09-25 |
2018-10-25 |
Колд Спринг Харбор Лаборатори |
Лечение синдрома ретта
|
|
EP3198006B1
(de)
|
2014-09-26 |
2021-03-24 |
Terumo BCT, Inc. |
Geplante fütterung
|
|
EP3215191B1
(de)
|
2014-11-05 |
2024-08-14 |
Voyager Therapeutics, Inc. |
Aadc-polynukleotide zur behandlung von morbus parkinson
|
|
KR20230145206A
(ko)
|
2014-11-14 |
2023-10-17 |
보이저 테라퓨틱스, 인크. |
조절성 폴리뉴클레오티드
|
|
CN114717264A
(zh)
|
2014-11-14 |
2022-07-08 |
沃雅戈治疗公司 |
治疗肌萎缩性侧索硬化(als)的组合物和方法
|
|
US11697825B2
(en)
|
2014-12-12 |
2023-07-11 |
Voyager Therapeutics, Inc. |
Compositions and methods for the production of scAAV
|
|
AU2016249798B2
(en)
|
2015-04-14 |
2022-05-26 |
Janssen Vaccines And Prevention B.V. |
Recombinant adenovirus expressing two transgenes with a bidirectional promoter
|
|
US10568516B2
(en)
|
2015-06-22 |
2020-02-25 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and devices for imaging and/or optogenetic control of light-responsive neurons
|
|
WO2017004592A1
(en)
|
2015-07-02 |
2017-01-05 |
Terumo Bct, Inc. |
Cell growth with mechanical stimuli
|
|
AU2016289496B2
(en)
|
2015-07-07 |
2021-02-04 |
Janssen Vaccines & Prevention B.V. |
Stabilized soluble pre-fusion RSV F polypeptides
|
|
CN107847580B
(zh)
|
2015-07-07 |
2022-08-12 |
扬森疫苗与预防公司 |
针对rsv的疫苗
|
|
GB201513010D0
(en)
*
|
2015-07-23 |
2015-09-09 |
Glaxosmithkline Biolog Sa |
Novel formulation
|
|
US20180230489A1
(en)
|
2015-10-28 |
2018-08-16 |
Voyager Therapeutics, Inc. |
Regulatable expression using adeno-associated virus (aav)
|
|
WO2017100674A1
(en)
|
2015-12-11 |
2017-06-15 |
The Trustees Of The University Of Pennsylvania |
Scalable purification method for aav1
|
|
US11015174B2
(en)
|
2015-12-11 |
2021-05-25 |
The Trustees Of The University Of Pennsylvania |
Scalable purification method for AAV8
|
|
EP3992283A1
(de)
|
2015-12-11 |
2022-05-04 |
The Trustees Of The University Of Pennsylvania |
Skalierbares reinigungsverfahren für aavrh10
|
|
EP3387138B2
(de)
|
2015-12-11 |
2026-05-27 |
The Trustees Of The University Of Pennsylvania |
Skalierbares reinigungsverfahren für aav9
|
|
US11155622B2
(en)
|
2015-12-17 |
2021-10-26 |
Psioxus Therapeutics Limited |
Virus encoding an anti-TCR-complex antibody or fragment
|
|
MX2018012094A
(es)
|
2016-04-05 |
2019-01-10 |
Janssen Vaccines & Prevention Bv |
Proteinas f de prefusion del virus respiratorio sincicial (vrs) solubles y estabilizadas.
|
|
AU2017248018A1
(en)
|
2016-04-05 |
2018-09-27 |
Janssen Vaccines & Prevention B.V. |
Vaccine against RSV
|
|
EP3448987A4
(de)
|
2016-04-29 |
2020-05-27 |
Voyager Therapeutics, Inc. |
Zusammensetzungen zur behandlung einer erkrankung
|
|
EP3448874A4
(de)
|
2016-04-29 |
2020-04-22 |
Voyager Therapeutics, Inc. |
Zusammensetzungen zur behandlung einer erkrankung
|
|
IL297576B2
(en)
|
2016-05-18 |
2024-02-01 |
Voyager Therapeutics Inc |
Compositions and methods of treating huntington's disease
|
|
US10584337B2
(en)
|
2016-05-18 |
2020-03-10 |
Voyager Therapeutics, Inc. |
Modulatory polynucleotides
|
|
WO2017205667A1
(en)
|
2016-05-25 |
2017-11-30 |
Terumo Bct, Inc. |
Cell expansion
|
|
SG11201810078PA
(en)
|
2016-05-30 |
2018-12-28 |
Janssen Vaccines & Prevention Bv |
Stabilized pre-fusion rsv f proteins
|
|
US11685883B2
(en)
|
2016-06-07 |
2023-06-27 |
Terumo Bct, Inc. |
Methods and systems for coating a cell growth surface
|
|
US11104874B2
(en)
|
2016-06-07 |
2021-08-31 |
Terumo Bct, Inc. |
Coating a bioreactor
|
|
US11001858B2
(en)
|
2016-06-20 |
2021-05-11 |
Janssen Vaccines & Prevention B.V. |
Potent and balanced bidirectional promoter
|
|
US10744196B2
(en)
|
2016-07-14 |
2020-08-18 |
Janssen Vaccines & Prevention B.V. |
HPV vaccines
|
|
GB201713765D0
(en)
|
2017-08-28 |
2017-10-11 |
Psioxus Therapeutics Ltd |
Modified adenovirus
|
|
KR102491752B1
(ko)
|
2016-08-29 |
2023-01-26 |
싸이오서스 테라퓨틱스 엘티디. |
이중특이성 T 세포 세포 관여자(BiTE)가 보강된 아데노바이러스
|
|
EP3831281B1
(de)
|
2016-08-30 |
2026-02-25 |
The Regents of The University of California |
Vorrichtungen und systeme für biomedizinische zielführung und verabreichung
|
|
US10626376B2
(en)
*
|
2016-11-14 |
2020-04-21 |
St. Jude Children's Research Hospital |
Method for isolating and purifying adeno-associated virus particles using salt
|
|
RU2663132C1
(ru)
*
|
2017-01-31 |
2018-08-01 |
Общество с ограниченной ответственностью "Саентифик Фьючер Менеджмент" (ООО "СФМ") |
Способ получения низкомолекулярной днк высокой степени чистоты
|
|
US11294165B2
(en)
|
2017-03-30 |
2022-04-05 |
The Board Of Trustees Of The Leland Stanford Junior University |
Modular, electro-optical device for increasing the imaging field of view using time-sequential capture
|
|
JP7393945B2
(ja)
|
2017-03-31 |
2023-12-07 |
テルモ ビーシーティー、インコーポレーテッド |
細胞増殖
|
|
US11624046B2
(en)
|
2017-03-31 |
2023-04-11 |
Terumo Bct, Inc. |
Cell expansion
|
|
US12234441B2
(en)
|
2017-03-31 |
2025-02-25 |
Terumo Bct, Inc. |
Cell expansion
|
|
AU2018253088B2
(en)
*
|
2017-04-10 |
2024-09-19 |
Epicentrx, Inc. |
Method for producing recombinant virus
|
|
BR112019021595A2
(pt)
*
|
2017-04-18 |
2020-05-12 |
Glaxosmithkline Intellectual Property Development Limited |
Célula produtora de vírus adeno-associado, vetor de ácido nucleico, métodos para produzir uma linhagem de células de empacotamento estável de vírus adeno-associado e uma partícula de vetor de vírus adeno-associado com defeito de replicação, célula de empacotamento de vírus adeno-associado, e, partícula de vetor de vírus adeno-associado com defeito de replicação.
|
|
EP3618839A4
(de)
|
2017-05-05 |
2021-06-09 |
Voyager Therapeutics, Inc. |
Zusammensetzungen und verfahren zur behandlung von amyotropher lateralsklerose (als)
|
|
MX2019013172A
(es)
|
2017-05-05 |
2020-09-07 |
Voyager Therapeutics Inc |
Composiciones y metodos para tratar la enfermedad de huntington.
|
|
KR102945203B1
(ko)
|
2017-05-08 |
2026-03-31 |
시애틀 프로젝트 코포레이션 |
알파바이러스 신생항원 벡터
|
|
CA3061278A1
(en)
|
2017-05-17 |
2018-11-22 |
Janssen Vaccines & Prevention B.V. |
Methods and compositions for inducing protective immunity against rsv infection
|
|
JOP20190269A1
(ar)
|
2017-06-15 |
2019-11-20 |
Voyager Therapeutics Inc |
بولي نوكليوتيدات aadc لعلاج مرض باركنسون
|
|
CA3070087A1
(en)
|
2017-07-17 |
2019-01-24 |
Voyager Therapeutics, Inc. |
Trajectory array guide system
|
|
US11512327B2
(en)
|
2017-08-03 |
2022-11-29 |
Voyager Therapeutics, Inc. |
Compositions and methods for delivery of AAV
|
|
AU2018333566A1
(en)
|
2017-09-15 |
2020-02-27 |
Janssen Vaccines & Prevention B.V. |
Method for the safe induction of immunity against RSV
|
|
PL3684381T3
(pl)
|
2017-09-21 |
2023-03-13 |
Codiak Biosciences, Inc. |
Wytwarzanie pęcherzyków zewnątrzkomórkowych w zawiesinie pojedynczych komórek z zastosowaniem zdefiniowanych chemicznie pożywek do hodowli komórkowych
|
|
MX2020003042A
(es)
|
2017-09-29 |
2020-11-18 |
Voyager Therapeutics Inc |
Rescate del fenotipo neurológico central y periférico de la ataxia de friedreich mediante administración intravenosa.
|
|
WO2019079242A1
(en)
|
2017-10-16 |
2019-04-25 |
Voyager Therapeutics, Inc. |
TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS)
|
|
TW202413649A
(zh)
|
2017-10-16 |
2024-04-01 |
美商航海家醫療公司 |
肌萎縮性脊髓側索硬化症(als)之治療
|
|
KR20240134250A
(ko)
|
2018-01-04 |
2024-09-06 |
아이코닉 테라퓨틱스, 인코포레이티드 |
항-조직 인자 항체, 항체-약물 결합체, 및 관련 방법
|
|
GB201801614D0
(en)
|
2018-01-31 |
2018-03-14 |
Psioxus Therapeutics Ltd |
Formulation
|
|
EP3762500A1
(de)
|
2018-03-06 |
2021-01-13 |
Voyager Therapeutics, Inc. |
Aus insektenzelle hergestellte teilweise selbstkomplementäre aav-genome
|
|
CN112424359A
(zh)
|
2018-05-15 |
2021-02-26 |
沃雅戈治疗公司 |
用于治疗帕金森氏病的组合物和方法
|
|
WO2019222444A2
(en)
|
2018-05-16 |
2019-11-21 |
Voyager Therapeutics, Inc. |
Directed evolution
|
|
US20210207167A1
(en)
|
2018-05-16 |
2021-07-08 |
Voyager Therapeutics, Inc. |
Aav serotypes for brain specific payload delivery
|
|
US20210254103A1
(en)
|
2018-07-02 |
2021-08-19 |
Voyager Therapeutics, Inc. |
Treatment of amyotrophic lateral sclerosis and disorders associated with the spinal cord
|
|
WO2020023612A1
(en)
|
2018-07-24 |
2020-01-30 |
Voyager Therapeutics, Inc. |
Systems and methods for producing gene therapy formulations
|
|
US12281321B2
(en)
|
2018-09-28 |
2025-04-22 |
Voyager Therapeutics, Inc. |
Frataxin expression constructs having engineered promoters and methods of use thereof
|
|
WO2020072849A1
(en)
|
2018-10-04 |
2020-04-09 |
Voyager Therapeutics, Inc. |
Methods for measuring the titer and potency of viral vector particles
|
|
KR20210090650A
(ko)
|
2018-11-07 |
2021-07-20 |
그릿스톤 바이오, 인코포레이티드 |
알파바이러스 신생항원 벡터 및 인터페론 억제제
|
|
PE20211469A1
(es)
|
2018-11-13 |
2021-08-05 |
Janssen Vaccines And Prevention B V |
Proteinas f de prefusion del vrs estabilizadas
|
|
CA3125770A1
(en)
|
2019-01-18 |
2020-07-23 |
Voyager Therapeutics, Inc. |
Methods and systems for producing aav particles
|
|
US20220243225A1
(en)
|
2019-04-29 |
2022-08-04 |
Voyager Therapeutics, Inc. |
SYSTEMS AND METHODS FOR PRODUCING BACULOVIRAL INFECTED INSECT CELLS (BIICs) IN BIOREACTORS
|
|
SG11202113187WA
(en)
|
2019-05-30 |
2021-12-30 |
Gritstone Bio Inc |
Modified adenoviruses
|
|
US20220267796A1
(en)
*
|
2019-06-28 |
2022-08-25 |
Takeda Pharmaceutical Company Limited |
Adeno-associated virus purification methods
|
|
CN110257467A
(zh)
*
|
2019-07-22 |
2019-09-20 |
福州市皮肤病防治院 |
一种检测肿瘤抑制因子p53显性抑制突变的试剂盒及其应用
|
|
EP4010465A1
(de)
|
2019-08-09 |
2022-06-15 |
Voyager Therapeutics, Inc. |
Zellkulturmedium zur verwendung bei der herstellung von gentherapieprodukten in bioreaktoren
|
|
EP4022070A1
(de)
|
2019-08-26 |
2022-07-06 |
Voyager Therapeutics, Inc. |
Kontrollierte expression viraler proteine
|
|
WO2021097281A1
(en)
|
2019-11-15 |
2021-05-20 |
Lonza Ltd |
Process and system for producing an inoculum
|
|
US20230183656A1
(en)
*
|
2020-05-14 |
2023-06-15 |
Merck Patent Gmbh |
Methods and compositions for purifying adeno associated virus particles or adenoviruses
|
|
IL300026A
(en)
|
2020-08-06 |
2023-03-01 |
Gritstone Bio Inc |
Multiepitope vaccine cassettes
|
|
EP4192514A1
(de)
|
2020-08-06 |
2023-06-14 |
Voyager Therapeutics, Inc. |
Zellkulturmedium zur verwendung bei der herstellung von gentherapieprodukten in bioreaktoren
|
|
GB202013940D0
(en)
|
2020-09-04 |
2020-10-21 |
Synpromics Ltd |
Regulatory nucleic acid sequences
|
|
US20230374542A1
(en)
|
2020-10-07 |
2023-11-23 |
Asklepios Biopharmaceutical, Inc. |
Therapeutic adeno-associated virus delivery of fukutin related protein (fkrp) for treating dystroglycanopathy. disorders including limb girdle 21 (lgmd21)
|
|
RU2745307C1
(ru)
*
|
2020-12-01 |
2021-03-23 |
федеральное государственное бюджетное учреждение «Национальный исследовательский центр эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи» Министерства здравоохранения Российской Федерации |
Способ очистки рекомбинантного аденовируса 26 серотипа (Ad26)
|
|
WO2022187473A2
(en)
|
2021-03-03 |
2022-09-09 |
Voyager Therapeutics, Inc. |
Controlled expression of viral proteins
|
|
WO2022187548A1
(en)
|
2021-03-03 |
2022-09-09 |
Voyager Therapeutics, Inc. |
Controlled expression of viral proteins
|
|
EP4314244B1
(de)
|
2021-03-23 |
2025-07-23 |
Terumo BCT, Inc. |
Zellerfassung und -erweiterung
|
|
US12152699B2
(en)
|
2022-02-28 |
2024-11-26 |
Terumo Bct, Inc. |
Multiple-tube pinch valve assembly
|
|
JP2025510977A
(ja)
*
|
2022-03-30 |
2025-04-15 |
シーエスエル・ベーリング・エルエルシー |
エンベロープ型ウイルスを精製する方法
|
|
USD1099116S1
(en)
|
2022-09-01 |
2025-10-21 |
Terumo Bct, Inc. |
Display screen or portion thereof with a graphical user interface for displaying cell culture process steps and measurements of an associated bioreactor device
|
|
WO2024054983A1
(en)
|
2022-09-08 |
2024-03-14 |
Voyager Therapeutics, Inc. |
Controlled expression of viral proteins
|
|
US20260062694A1
(en)
*
|
2024-08-29 |
2026-03-05 |
GE Precision Healthcare LLC |
Systems and methods to improve nucleic acid synthesis and production
|
|
CN120446469B
(zh)
*
|
2025-05-08 |
2026-05-29 |
河南省科学院物理研究所 |
一种提升荧光微球标记抗体冻干品稳定性的方法
|